Persistent Asset Partners’s PureTech Health PRTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,759
Closed -$26.1K 882
2026
Q1
$26.1K Hold
1,759
0.01% 275
2025
Q4
$29.4K Buy
1,759
+74
+4% +$1.27K 0.01% 307
2025
Q3
$31.2K Hold
1,685
0.02% 195
2025
Q2
$29.1K Buy
+1,685
New +$29.7K 0.02% 159

Persistent Asset Partners's PRTC Position: Q2 2026 in Review

Persistent Asset Partners sold out of PureTech Health (PRTC) in Q2 2026, closing a stake of 1,759 shares — an estimated $26.1K sold.

Persistent Asset Partners first reported a position in PRTC in Q2 2025 and held it in 4 quarters. The position peaked at $31.2K in Q3 2025. 0 funds tracked by Wall St. Rank hold PRTC as of Q2 2026.

  • Persistent Asset Partners reported no remaining PureTech Health position as of Q2 2026 after selling out during the quarter.
  • Persistent Asset Partners sold 1,759 PureTech Health shares in Q2 2026, an estimated $26.1K.
  • Persistent Asset Partners first reported a position in PureTech Health in Q2 2025 and held it in 4 quarters.
  • Persistent Asset Partners's PureTech Health position peaked at $31.2K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held PureTech Health as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.